Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong
· Delayed Price · Currency is HKD 4.290
0.00 (0.00%)
At close: Mar 10, 2026
Jiangsu Recbio Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Other Revenue | 18.22 | 27.01 | 30.38 | 5.33 | 6.2 | 1.46 | Upgrade
|
| Revenue | 29.11 | 27.01 | 30.38 | 5.33 | 6.2 | 1.46 | Upgrade
|
| Revenue Growth (YoY) | -32.92% | -11.10% | 470.46% | -14.10% | 325.17% | - | Upgrade
|
| Cost of Revenue | 2.91 | 11.06 | 8.04 | - | - | - | Upgrade
|
| Gross Profit | 26.2 | 15.95 | 22.34 | 5.33 | 6.2 | 1.46 | Upgrade
|
| Selling, General & Admin | 103.99 | 111.67 | 152.24 | 163.96 | 146.51 | 18.42 | Upgrade
|
| Research & Development | 570.48 | 476.12 | 487.85 | 716.44 | 472.95 | 130.52 | Upgrade
|
| Operating Expenses | 674.47 | 587.79 | 640.09 | 880.4 | 619.46 | 148.94 | Upgrade
|
| Operating Income | -648.27 | -571.85 | -617.75 | -875.08 | -613.26 | -147.48 | Upgrade
|
| Interest Expense | -22.61 | -18.9 | -13.57 | -3.53 | -56.31 | -37.11 | Upgrade
|
| Interest & Investment Income | 10.68 | 21.38 | 45.58 | 23.98 | 10.36 | 2.63 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.89 | 8.97 | 17.5 | 115.06 | -8.49 | -2.88 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.94 | 2.29 | -2.12 | 0.02 | -1.06 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | -652.36 | -558.1 | -570.36 | -739.55 | -668.76 | -184.78 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.63 | - | - | 3.56 | 11.22 | 5.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.1 | 0.06 | 6.61 | - | -0.02 | -0.02 | Upgrade
|
| Asset Writedown | - | -3.86 | -8.69 | - | - | - | Upgrade
|
| Pretax Income | -651.83 | -561.9 | -572.44 | -736 | -657.57 | -179.4 | Upgrade
|
| Earnings From Continuing Operations | -652.91 | -561.9 | -572.44 | -736 | -657.57 | -179.4 | Upgrade
|
| Minority Interest in Earnings | -0.99 | -0.49 | 0.49 | 13.29 | 0.01 | - | Upgrade
|
| Net Income | -653.91 | -562.39 | -571.96 | -722.7 | -657.56 | -179.4 | Upgrade
|
| Preferred Dividends & Other Adjustments | -4.93 | -4.93 | - | - | - | - | Upgrade
|
| Net Income to Common | -648.98 | -557.46 | -571.96 | -722.7 | -657.56 | -179.4 | Upgrade
|
| Shares Outstanding (Basic) | 478 | 479 | 481 | 474 | 421 | 309 | Upgrade
|
| Shares Outstanding (Diluted) | 478 | 479 | 481 | 474 | 421 | 309 | Upgrade
|
| Shares Change (YoY) | -0.33% | -0.50% | 1.42% | 12.52% | 36.60% | 7.47% | Upgrade
|
| EPS (Basic) | -1.36 | -1.16 | -1.19 | -1.52 | -1.56 | -0.58 | Upgrade
|
| EPS (Diluted) | -1.36 | -1.16 | -1.19 | -1.52 | -1.56 | -0.58 | Upgrade
|
| Free Cash Flow | -558.02 | -636.66 | -850.11 | -876.27 | -710.79 | -208.62 | Upgrade
|
| Free Cash Flow Per Share | -1.17 | -1.33 | -1.77 | -1.85 | -1.69 | -0.68 | Upgrade
|
| Gross Margin | 90.00% | 59.05% | 73.54% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -2226.64% | -2117.56% | -2033.60% | -16433.33% | -9892.89% | -10115.02% | Upgrade
|
| Profit Margin | -2229.10% | -2064.30% | -1882.86% | -13571.89% | -10607.53% | -12304.53% | Upgrade
|
| Free Cash Flow Margin | -1916.66% | -2357.56% | -2798.55% | -16455.78% | -11466.17% | -14308.92% | Upgrade
|
| EBITDA | -554.02 | -501.05 | -569.87 | -847.67 | -598.36 | -140.92 | Upgrade
|
| D&A For EBITDA | 94.24 | 70.79 | 47.88 | 27.41 | 14.9 | 6.56 | Upgrade
|
| EBIT | -648.27 | -571.85 | -617.75 | -875.08 | -613.26 | -147.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.